Ping An Biomedical Co., Ltd. logo

Ping An Biomedical Co., Ltd.

PASW

NASDAQConsumer CyclicalApparel - Manufacturers

Previous close

$0.1349

−$0.0011 · -0.81%

Aug 21, 4:00 PM ET

Pre-market

$0.1349

$0.00 · 0.00%

Aug 24, 4:00 AM ET

PASW company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

65

Undervalued

Momentum

24

Weakening

Sentiment

50

Mixed

Risk resilience

14

Extreme Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Ping An Biomedical Co., Ltd. delivers comprehensive supply chain management services tailored for the clothing sector. The company furnishes integrated solutions to its clients, covering a wide spectrum of offerings from initial yarn products and various textiles to fully manufactured garments. Its operations are organized into two primary divisions: Yarns and Finished Garments. Established in 2013 by Yuk Yin Li and Sek Yan Ko, the firm's main office is situated in Hong Kong.

Industry
Apparel - Manufacturers
Sector
Consumer Cyclical
Headquarters
HK
CEO
Pijun Liu
Listed since
Jul 18, 2025
Employees
7

Market position

Day range

Current $0.1349

52-week range

Current $0.1349

Open
$0.1327
Previous close
$0.136
Volume
30.18K
0.05× average
Average volume
560.33K
Average daily volume
Market cap
2.49M USD
Beta
2.3
Market reference 1
50-day average
$0.1461
-7.68% below average
200-day average
$0.2519
-46.46% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
9.3M CNY
P/E (TTM)
P/B (TTM)
P/S (TTM)
0.49×
EV / EBITDA
-0.65×
Earnings yield
0.00%
Free cash flow yield
0.00%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
2.78%
Operating margin
-43.05%
Net margin
-37.57%
Return on equity
-28.36%
Return on assets
-18.75%
Return on invested capital
-23.05%

Financial health

Debt / equity
0.23×
Current ratio
2.76×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends20%-3%-26%-49%Gross margin, FY2021: 14.34%Gross margin, FY2022: 12.35%Gross margin, FY2023: 5.14%Gross margin, FY2024: 6.18%Gross margin, FY2025: 2.78%Operating margin, FY2021: 8.31%Operating margin, FY2022: 9.44%Operating margin, FY2023: 0.74%Operating margin, FY2024: -0.00%Operating margin, FY2025: -43.05%Net margin, FY2021: 5.24%Net margin, FY2022: 6.31%Net margin, FY2023: -1.20%Net margin, FY2024: -1.47%Net margin, FY2025: -37.57%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 14.34%. Gross margin FY2022 12.35%. Gross margin FY2023 5.14%. Gross margin FY2024 6.18%. Gross margin FY2025 2.78%. Operating margin FY2021 8.31%. Operating margin FY2022 9.44%. Operating margin FY2023 0.74%. Operating margin FY2024 -0.00%. Operating margin FY2025 -43.05%. Net margin FY2021 5.24%. Net margin FY2022 6.31%. Net margin FY2023 -1.20%. Net margin FY2024 -1.47%. Net margin FY2025 -37.57%.

Income trends

Revenue

34.15M CNY-61.03%

Operating income

−14.7M CNY-720913.73%

Net income

−12.83M CNY-899.03%
Income trends across reported periods127.47M CNY75.77M CNY24.07M CNY−27.63M CNYRevenue, FY2021: 99.52M CNYRevenue, FY2022: 114.55M CNYRevenue, FY2023: 82.56M CNYRevenue, FY2024: 87.62M CNYRevenue, FY2025: 34.15M CNYOperating income, FY2021: 8.27M CNYOperating income, FY2022: 10.82M CNYOperating income, FY2023: 612.48K CNYOperating income, FY2024: −2.04K CNYOperating income, FY2025: −14.7M CNYNet income, FY2021: 5.21M CNYNet income, FY2022: 7.23M CNYNet income, FY2023: −993.94K CNYNet income, FY2024: −1.28M CNYNet income, FY2025: −12.83M CNYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 99.52M CNY. Revenue FY2022 114.55M CNY. Revenue FY2023 82.56M CNY. Revenue FY2024 87.62M CNY. Revenue FY2025 34.15M CNY. Operating income FY2021 8.27M CNY. Operating income FY2022 10.82M CNY. Operating income FY2023 612.48K CNY. Operating income FY2024 −2.04K CNY. Operating income FY2025 −14.7M CNY. Net income FY2021 5.21M CNY. Net income FY2022 7.23M CNY. Net income FY2023 −993.94K CNY. Net income FY2024 −1.28M CNY. Net income FY2025 −12.83M CNY.
Metric (CNY)FY2025FY2024FY2023FY2022FY2021
Revenue34.15M CNY87.62M CNY82.56M CNY114.55M CNY99.52M CNY
Cost of goods sold33.2M CNY82.21M CNY78.32M CNY100.4M CNY85.25M CNY
Gross profit949.51K CNY5.42M CNY4.24M CNY14.14M CNY14.27M CNY
Selling, general, and administrative6.3M CNY4.85M CNY3.21M CNY3.11M CNY3.37M CNY
Operating expenses15.65M CNY5.42M CNY3.63M CNY3.33M CNY6M CNY
Interest income326.35K CNY2.03K CNY156.14K CNY42.34K CNY4.42K CNY
Interest expense307.06K CNY705.27K CNY1.74M CNY1.57M CNY1.36M CNY
Depreciation and amortization5.59K CNY450.78K CNY416.75K CNY414.44K CNY391.49K CNY
Operating income−14.7M CNY−2.04K CNY612.48K CNY10.82M CNY8.27M CNY
Net income−12.83M CNY−1.28M CNY−993.94K CNY7.23M CNY5.21M CNY

Company facts updated Aug 24, 2026.

Earnings

Latest fiscal-year EPS
0
FY2025
Latest fiscal-year revenue
34.15M CNY
FY2025 · -61.03% year over year

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual EPS trend0.420.250.08-0.09FY21FY22FY23FY24FY25

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual revenue trend122.59M90.43M58.27M26.11MFY21FY22FY23FY24FY25

PASW news

PASW peers

Continue in GoAI

Research PASW

research.disclaimer